Cory Jubinville, PhD's Stock Coverage
| PRMEPrime Medicine, Inc. | Oct 05, 2026 | BUY | Reiterated | $6.00 | 13Ratings | -16.07% | ||
| TNYATenaya Therapeutics | Aug 06, 2026 | BUY | Reiterated | $4.00 | 33Ratings | -14.82% | ||
| MREOMereo Biopharma Group Plc | Jan 12, 2026 | HOLD | Reiterated | ― | 14Ratings | -81.35% | ||
| SIONSionna Therapeutics, Inc. | Dec 23, 2025 | BUY | Initiated | $60.00 | 1Ratings | -88.60% | ||
| IKTInhibikase Therapeutics | Dec 01, 2025 | BUY | Initiated | $5.00 | 1Ratings | +33.30% | ||
| TECXTectonic Therapeutic | Nov 18, 2025 | BUY | Reiterated | $88.00 | 5Ratings | +25.52% | ||
| RCKTRocket Pharmaceuticals | Nov 07, 2025 | BUY | Reiterated | $9.00 | 17Ratings | -51.62% | ||
| TARSTarsus Pharmaceuticals | Nov 05, 2025 | BUY | Reiterated | $84.00 | 14Ratings | +48.46% | ||
| LRMRLarimar Therapeutics | Nov 05, 2025 | BUY | Reiterated | $22.00 | 21Ratings | -4.51% | ||
| LQDALiquidia Technologies | Nov 03, 2025 | BUY | Reiterated | $67.00 | 22Ratings | +169.37% |
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >Cory Jubinville, PhD activity FAQ
What is the performance of Cory Jubinville, PhD's recommendations?
The percentage of profitable recommendations made by Cory Jubinville, PhD is 50.75%, and the average return per transaction is 19.20%.
What stocks does Cory Jubinville, PhD cover?
Cory Jubinville, PhD mostly covers Prime Medicine, Inc., Tenaya Therapeutics, Mereo Biopharma Group Plc stocks.
What was Cory Jubinville, PhD's most profitable rating?
Cory Jubinville, PhD’s most profitable rating was a buy on Liquidia Technologies stock on Aug 06, 2025. The return on the trade was 340.20%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here